Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangningtongluo Tablet in Prediabetes
NCT05126251Phase 2Unknown
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tangningtongluo in prediabetes, sponsored by Beijing University of Chinese Medicine. Status: unknown.
02
Drugs
tangningtongluo
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05126251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05126251.